FOLFIRI in Combination With Cetuximab in the First-line Treatment of Metastatic Colorectal Cancer Including a Regular Dermal Prophylaxis to Prevent Acneiforme Follicular Exanthema

NCT01315990 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

165

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic

Interventions

DRUG: FOLFIRI + Cetuximab

Sponsor

Dr. Carl Schimanski